ArticleBMJ evidence-based medicine2018

Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism.

Lori-Ann LinkinsPubMed ↗Publisher ↗

No numbers read from the abstract.